Advertisement Aptiv Solutions establishes Adaptive Clinical Trials Innovation Center - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Aptiv Solutions establishes Adaptive Clinical Trials Innovation Center

Aptiv Solutions has established an Adaptive Clinical Trials Innovation Center to improve drug development process through the use of adaptive designs.

The experts at the Adaptive Clinical Trials Innovation Center work with clients to assist with the trial design, simulation and execution, develop adaptive trials software tools, and work with project teams in clinical operations, data management and statistics groups during study conduct.

Reinhard Eisebitt will be the executive vice president and head of Innovation Center.

Judith Quinlan is appointed as the senior vice president of Trial Design Implementation.

Andrew Grieve is named as the senior vice president of Clinical Research Methodology,

Vladimir Dragalin will serve as the senior vice president of Software Development and Consulting.

Gernot Wassmer is the senior vice president and principle software architect of ADDPLAN.

Eisebitt said Aptiv Solutions has combined clinical execution capabilities, statistical and scientific expertise, and a suite of integrated technology to provide clients with a full-service adaptive clinical trial offering.

Aptiv Solutions integrates the resources and expertise of six recently merged companies: Averion International, Trio Clinical Research, Fulcrum Pharma, ClinResearch, Niphix and ADDPLAN.